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Introduction and Aim 
Acyl-ghrelin has been reported to increase food intake and adiposity and it is the best studied of the orexigenic 
gastrointestinal hormones. On the other hand, desacyl-ghrelin – DAG (the unacylated form of the hormone) has been 
reported as a potential player on carbohydrate metabolism. However, the potential impact of DAG on glucose 
homeostasis remains uncertain. In this study we aim to assess the association between DAG and insulin sensitivity.  
Matherials and Methods 
We studied 95 normal-weight and 223 obese premenopausal caucasian women; with no known health condition 
(other than obesity, in the obese group) or administration of any drug (other than oral contraceptives). The two 
groups, adjusted for age, were characterized for BMI, fasting glucose and insulin levels and DAG. DAG plasma levels 
were determined by ELISA (Cayman Chemical, USA), insulin by immunoluminescence (Siemens Healthcare 
Diagnostics, UK) and glucose by an automatic chemistry test (Ortho-Clinical Diagnosis Inc, USA).  Insulin resistance 
was assessed by HOMA-IR (Homeostatic Model Assessment of Insulin Resistance). In each group we assessed for the 
presence of correlations of DAG and BMI, glucose and HOMA-IR.  
Results 
DAG levels were higher and  glucose and HOMA were lower in normal-weight women (p < 0.001 for all). Dysglycemia 
(diabetes or intermediate hyperglycemia) was present in 21.1% of obese women but it was absent at the normal-
weight group.  
 
No significant correlation was observed between DAG and BMI,  glucose or HOMA-IR in either normal-weight or 
obese women. 
Conclusions 
These results suggest that although obese women have significantly lower DAG, and that some of them present 
dysglycemia, DAG is not a major regulator of insulin sensitivity.  
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  Normal-Weight Obese p value 
Age (Yrs) 34.21±8.38 34.45±8.17 ns 
BMI (Kg/m2) 21.4±1.70 42.0±7.80 <0.001 
DAG (pg/mL) 350.16±251.88 221.2±149.0 <0.001 
Glycemia (mg/mL) 80.9±7.20 89.1±28.4 <0.001 
HOMA-IR 1.19±0.76 3.50±3.20 <0.001 
